Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Life-saving Treatments for Severe Respiratory Diseases
Neshima is developing life-saving treatments for severe lung diseases using LiFT™, a patented foam-based delivery platform. LiFT™ enables deep and uniform therapeutic delivery to the alveoli, overcoming the limitations of inhalers, nebulizers, and intravenous treatments. Our lead applications include a regenerative cell therapy for COPD. As a cost-effective PoC we are also developing an ICU-delivered antibiotic treatment for antimicrobial-resistant infections. A fully functional prototype has been tested in large animals. Neshima is targeting a $10 billion U.S. market with a B2B model.
Identity
| Name | Neshima Medical |
|---|---|
| Slug | neshima |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMSw_YoLDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District,South District |
| HQ city | Haifa |
| HQ address | Haifa, Israel |
Web & social
| Website | https://neshimamedical.com/ |
|---|---|
| https://linkedin.com/company/neshima-medical-ltd |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
patientsmedical-devicesrespiratoryhealthcare-providershospitalsmedical-technologiesdrug-deliverypatent-pending
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}